New
Guidelines Needed For Interpreting Continuous Glucose Monitoring Reports In Those Without Diabetes, Say Researchers
With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small sensors that penetrate the skin to measure glucose levels in real time—there is high consumer interest in the use of these devices for health and wellness, even among people without diabetes. However, a new study led by researchers from Boston University Chobanian & Avedisian School of Medicine has found there is no consensus on how clinical experts interpret CGM reports from people without this disease.
